UNIQA Ventures GmbH
VC Fund
Vienna, Austria
UNIQA Ventures GmbH is a VC fund in Vienna focused on FinTech and Insurance. UNIQA Ventures GmbH is the Venture Capital arm of UNIQA Insurance Group AG, a leading insurance carrier in Central & Eastern Europe and a pioneer in Corporate-backed Venture Capital in Austria and CEE. Based in Vienna, Austria, the firm is investing in outstanding business models driven by strong teams and a clear vision to shape the future ofkey industries. Investment areas are the future of Health, Mobility, Intelligent Home and FinTech/InsurTech as well as enabling technologies such as IoT, Blockchain, ML/AI.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 27%
Last updated:
For AI agents: llms.txt
Industries UNIQA Ventures GmbH invests in
Stages UNIQA Ventures GmbH invests in
Countries UNIQA Ventures GmbH invests in
Round sizes
Round size
- Seed
- $435k–$10M
- Series A
- $5M–$50M
- Series B
- $15M–$125M
Investment Focus
Industry
- FinTech 9 (22%)
- Insurance 9 (22%)
- Health Care 8 (20%)
- InsurTech 7 (17%)
- Financial Services 7 (17%)
Stage
- Series A 12 (29%)
- Seed 7 (17%)
- Series B 5 (12%)
- Series C 3 (7%)
- Funding Round 3 (7%)
Country
- Austria 6 (15%)
- Germany 6 (15%)
- United Kingdom 4 (10%)
- Spain 2 (5%)
- Ireland 2 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ifeel is the all-in-one emotional well-being platform for organisations and individuals. ifeel leverages technology to make effective mental healthcare more scalable for organisations operating globally and more accessible and convenient for their employees and clients. Using a blend of data driven technologies and professional one-on-oneinteractions with licensed psychologists, ifeel is the complete solution to cover the full spectrum of emotional well-being needs. | $19.9M / Series B / May 29, 2024 | ||
| GoUrban is an operating system for the mobility of the present & future. Operators can now manage cars, scooters, moped-sharing systems & more, focusing directly on operations, optimizing units, and cutting irrelevant costs. | $3.3M / Mar 18, 2024 | ||
| Doctorly is a health tech company that offers a cloud-based practice management platform for doctors. The company has a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools and workflowsdirectly with our doctors & patients.Doctorly is driven by a desire to make positive and meaningful changes to the healthcare industry internationally. | $7.1M / Series A / Nov 09, 2023 | ||
| Abi Global Health is an information technology company that focuses on the hospital and healthcare industry and offers an online-based platform that connects people to doctors online to get medical advice. Its platform enables its users to get access to trusted advice from doctors, its virtual health assistant, Abi, connects people to a globalnetwork of doctors for quick answers or in-depth consultations. | $5M / Series A / Mar 30, 2023 | ||
| Doctorly is a health tech company that offers a cloud-based practice management platform for doctors. The company has a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools and workflowsdirectly with our doctors & patients.Doctorly is driven by a desire to make positive and meaningful changes to the healthcare industry internationally. | $10M / Series A / Mar 01, 2023 | ||
| ifeel is the all-in-one emotional well-being platform for organisations and individuals. ifeel leverages technology to make effective mental healthcare more scalable for organisations operating globally and more accessible and convenient for their employees and clients. Using a blend of data driven technologies and professional one-on-oneinteractions with licensed psychologists, ifeel is the complete solution to cover the full spectrum of emotional well-being needs. | $10.4M / Series A / Nov 15, 2022 | ||
| Insly is cloud-based insurance software for insurance brokers and agents to replace papers and spreadsheets. Its goal is to make insurance easy to understand, manage, and buy for both service providers and end users.Insly is a spin-off from IIZI Group – most successful insurance broker group in CEE region starting from 2000. Their core teamconsists of the founders and key employees of IIZI Group, who contributed to revolutionising the insurance business with their innovative and business focused IT solutions.Insly was launched in 2000 in London, United Kingdom. | $1.2M / Convertible Note / Sep 14, 2022 | ||
| Insly is cloud-based insurance software for insurance brokers and agents to replace papers and spreadsheets. Its goal is to make insurance easy to understand, manage, and buy for both service providers and end users.Insly is a spin-off from IIZI Group – most successful insurance broker group in CEE region starting from 2000. Their core teamconsists of the founders and key employees of IIZI Group, who contributed to revolutionising the insurance business with their innovative and business focused IT solutions.Insly was launched in 2000 in London, United Kingdom. | $1.1M / Seed / Sep 14, 2022 | ||
| Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020. | $125M / Series B / Jul 11, 2022 | ||
| GoUrban is an operating system for the mobility of the present & future. Operators can now manage cars, scooters, moped-sharing systems & more, focusing directly on operations, optimizing units, and cutting irrelevant costs. | Seed / Jun 29, 2022 | ||
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does UNIQA Ventures GmbH invest in?
UNIQA Ventures GmbH invests primarily in FinTech, Insurance and Health Care startups, most often at Series A and Seed stage. Most of the 41 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is UNIQA Ventures GmbH's check size?
UNIQA Ventures GmbH typically joins rounds of $435k–$10M at Seed, $5M–$50M at Series A and $15M–$125M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds UNIQA Ventures GmbH participates in.
When did UNIQA Ventures GmbH last invest?
The most recent investment recorded for UNIQA Ventures GmbH closed in May 2024. Shizune tracks 41 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
